Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-264038

Chief Executive Officer sold 49,670 shares at $241.01 ($11,970,967)

  • Chief Executive Officer acquired 49,670 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

TABUTEAU HERRIOT · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-09 Exercise or conversion : show line 1 in the form 10b5-1 +49,670 $4.95 $245,867 56,899 D
2026-06-09 Sale : show line 2 in the form 10b5-1 −49,670 $241.01 $11,970,967 7,229 D
Open-market sales · 49,670 sh · avg $241.01 · $11,970,967

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-09 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −49,670 99,330 D
Loading xslF345X06/ownership.xml…